Last Updated on eMC 17-05-2018 View medicine  | AstraZeneca UK Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Correction of spelling/typing errors

Reasons for adding or updating:

  • Improved presentation of PIL
  • Correction of spelling/typing errors
  • Change to section 4 - how to report a side effect

Reasons for adding or updating:

  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to information for healthcare professionals

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors

Reasons for adding or updating:

  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to information for healthcare professionals

Reasons for adding or updating:

  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • New PIL for new product